| Product Code: ETC13279752 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Enteric Disease Testing-Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Enteric Disease Testing-Treatment Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Enteric Disease Testing-Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 North America Enteric Disease Testing-Treatment Market - Industry Life Cycle |
3.4 North America Enteric Disease Testing-Treatment Market - Porter's Five Forces |
3.5 North America Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 North America Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.8 North America Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Testing Technology, 2021 & 2031F |
3.9 North America Enteric Disease Testing-Treatment Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 North America Enteric Disease Testing-Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Enteric Disease Testing-Treatment Market Trends |
6 North America Enteric Disease Testing-Treatment Market, 2021 - 2031 |
6.1 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Bacterial Enteric Diseases, 2021 - 2031 |
6.1.3 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Viral Enteric Diseases, 2021 - 2031 |
6.1.4 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Parasitic Enteric Diseases, 2021 - 2031 |
6.2 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Therapeutics, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Campylobacter, 2021 - 2031 |
6.2.3 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Cryptosporidium, 2021 - 2031 |
6.2.4 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By E-Coli, 2021 - 2031 |
6.2.5 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Enteroviruses, 2021 - 2031 |
6.2.6 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By RhinoViruses, 2020 - 2028 |
6.2.7 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By RotaVirus, 2020 - 2028 |
6.2.8 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Salmonellosis, 2020 - 2028 |
6.2.9 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Shigellosis, 2020 - 2028 |
6.3 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Molecular Diagnostics, 2021 - 2031 |
6.3.3 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031 |
6.3.4 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Immunoassays, 2021 - 2031 |
6.3.5 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Differential Light Scanning, 2021 - 2031 |
6.3.6 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Information Technology, 2021 - 2031 |
6.3.7 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By AI, 2021 - 2031 |
6.3.8 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Liposomes, 2021 - 2031 |
6.3.9 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Flow Cytometry, 2021 - 2031 |
6.4 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By End users, 2021 - 2031 |
6.4.2 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.4.4 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Physician Offices, 2020 - 2028 |
7 North America Enteric Disease Testing-Treatment Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.2.1 United States (US) Enteric Disease Testing-Treatment Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.2.2 Canada Enteric Disease Testing-Treatment Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.2.3 Rest of North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3 North America Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
7.3.1 United States (US) Enteric Disease Testing-Treatment Market, Revenues & Volume, By Therapeutics, 2021 - 2031 |
7.3.2 Canada Enteric Disease Testing-Treatment Market, Revenues & Volume, By Therapeutics, 2021 - 2031 |
7.3.3 Rest of North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Therapeutics, 2021 - 2031 |
7.4 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.4.1 United States (US) Enteric Disease Testing-Treatment Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.4.2 Canada Enteric Disease Testing-Treatment Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.4.3 Rest of North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.5 North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By End users, 2021 - 2031 |
7.5.1 United States (US) Enteric Disease Testing-Treatment Market, Revenues & Volume, By End users, 2021 - 2031 |
7.5.2 Canada Enteric Disease Testing-Treatment Market, Revenues & Volume, By End users, 2021 - 2031 |
7.5.3 Rest of North America Enteric Disease Testing-Treatment Market, Revenues & Volume, By End users, 2021 - 2031 |
8 North America Enteric Disease Testing-Treatment Market Key Performance Indicators |
9 North America Enteric Disease Testing-Treatment Market - Export/Import By Countries Assessment |
10 North America Enteric Disease Testing-Treatment Market - Opportunity Assessment |
10.1 North America Enteric Disease Testing-Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Enteric Disease Testing-Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.3 North America Enteric Disease Testing-Treatment Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
10.4 North America Enteric Disease Testing-Treatment Market Opportunity Assessment, By Testing Technology, 2021 & 2031F |
10.5 North America Enteric Disease Testing-Treatment Market Opportunity Assessment, By End users, 2021 & 2031F |
11 North America Enteric Disease Testing-Treatment Market - Competitive Landscape |
11.1 North America Enteric Disease Testing-Treatment Market Revenue Share, By Companies, 2022 |
11.2 North America Enteric Disease Testing-Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here